Earnings Summary

Io Biotech, Inc.’s revenue jumped +Inf% since last year same period to $1.11Mn in the Q4 2023. On a quarterly growth basis, Io Biotech, Inc. has generated +Inf% jump in its revenue since last 3-months.

Io Biotech, Inc.’s net profit fell -30.44% since last year same period to $-26.18Mn in the Q4 2023. On a quarterly growth basis, Io Biotech, Inc. has generated -20.77% fall in its net profits since last 3-months.

Io Biotech, Inc.’s net profit margin jumped NaN% since last year same period to -2358.74% in the Q4 2023. On a quarterly growth basis, Io Biotech, Inc. has generated NaN% jump in its net profit margins since last 3-months.

Io Biotech, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.32 - a 17.95% jump from last quarter’s estimates.

Io Biotech, Inc.’s earning per share (EPS) estimates for the current year stand at -0.32.

Io Biotech, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Io Biotech, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.